At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CPRX Catalyst Pharmaceuticals
Trading 04-27 09:44:14 EDT
27.96
+0.59
+2.16%
High28.01Low27.30Vol119.85K
Open27.56D1 Closing27.37Amplitude2.59%
Mkt Cap3.41BTradable Cap3.22BTotal Shares122.12M
T/O3.32MT/O Rate0.10%Tradable Shares115.02M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Firdapse Momentum And Growing Agamree Contribution
Simply Wall St.  ·  05:08
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Firdapse Momentum And Growing Agamree Contribution
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Dow Jones  ·  04-25 05:21
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Catalyst Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market
Dow Jones  ·  04-23
Catalyst Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Dow Jones  ·  04-22
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Catalyst Pharmaceuticals (CPRX) Is Up 5.3% After Stronger Revenue And Expanded M&A Pipeline - What's Changed
Simply Wall St.  ·  04-18
Catalyst Pharmaceuticals (CPRX) Is Up 5.3% After Stronger Revenue And Expanded M&A Pipeline - What's Changed
Catalyst Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market
Dow Jones  ·  04-18
Catalyst Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
Dow Jones  ·  04-16
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum
Simply Wall St.  ·  04-14
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  04-14
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  04-10
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market
Dow Jones  ·  04-09
Catalyst Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  04-07
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  03-31
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
Dow Jones  ·  03-28
Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  03-27
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Pharmaceuticals Inc. Stock Advances 3.2%, Outperforms Peers
Dow Jones  ·  03-26
Catalyst Pharmaceuticals Inc. Stock Advances 3.2%, Outperforms Peers
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  03-24
Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback?
Simply Wall St.  ·  03-23
Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback?
Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
Dow Jones  ·  03-20
Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
Catalyst Pharmaceuticals files 8-K/A to correct signature date on March 18, 2026 filing
Reuters  ·  03-19
Catalyst Pharmaceuticals files 8-K/A to correct signature date on March 18, 2026 filing
No data available

Introduction

Company Name.
Catalyst Pharmaceuticals
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Issue price:
--